Evaluation of Omeprazole prescription for stress ulcer prophylaxis in a public trauma referral hospital: monocentric cross-sectional study

Authors

DOI:

https://doi.org/10.30968/jhphs.2025.162.1206

Abstract

Objective: To evaluate the compliance to indication and prescription of Omeprazole, for stress ulcer prophylaxis in intensive care units and and hospital wards, in a public emergency and urgency hospital that is a referral in trauma, according to scientific evidence and criteria used in the present study. Method: This is a retrospective cross-sectional study. The research was carried out over a period of one day, on March 15,2023. Clinical data, previous medical history, health conditions, and eletronic prescriptions were analysed. Data were collected from all hospitalized patients aged 18 years or older. Patients without a Hospital Admission Authorization and those using omeprazole for other treatment purposes were excluded. To assess the indication for prophylaxis, the recommendations from the UpToDate database were used, on the risk factors for stress ulcers, in this database, were also listed in the guideline of the Portuguese Society of Intensive Care or in the BMJ-Best Practice, according to the practice guideline “Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline”. The data were analysed in the R software, version 4.1.1, and the results were presented in tables. Results: A total of 307 patients were screened, of whom 254 were considered eligible for evaluation of prophylaxis indication. Overall, 61.4%of patients showed adequate use. However, for 72.8% of patients prescribed omeprazole, there was no indication for its use, and among patients with an indication, prophylaxis was omitted for 17.1%. The non-critical patients’ wards had a percentage of 88.9% of patients prescribed prophylaxis, but without indication, while intensive care units had 31.4%. Conclusion: The study showed a considerable inadequacy in the use of stress ulcer prophylaxis in non-critical wards and, although smaller, a relevant inadequacy in intensive care units. Therefore, stands out the importance of establishing institutional interventions, such as a clinical protocol, to guide prescription practice.

Downloads

Download data is not yet available.

References

ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;56(4):347-379. doi:10.1093/ajhp/56.4.347

Santos YAPD, Younes-Ibrahim MS, Crozatti LL, et al. Adherence to a stress ulcer prophylaxis protocol by critically ill patients: a prospective cohort study. Adesão a um protocolo de profilaxia de úlcera de estresse em pacientes críticos: estudo de coorte prospectiva. Rev Bras Ter Intensiva. 2020;32(1):37-42. doi:10.5935/0103-507x.20200007

Eastern Association for the Surgery of Trauma. Practice management guidelines for stress ulcer prophylaxis. EAST Practice Management Guidelines Committee.New Jersey;2008.

Ye Z, Reintam Blaser A, Lytvyn L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020;368:l6722. doi:10.1136/bmj.l6722.

He N, Yan Y, Su S, Ge Q, Zhai S. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies. Ann Pharmacother. 2022;56(9):988-997. doi:10.1177/10600280211059040

Wang Y, Parpia S, Ge L, et al. Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-Analysis. NEJM Evid. 2024;3(7):EVIDoa2400134. doi:10.1056/EVIDoa2400134

Forgerini M, Mieli S, Mastroianni PC. Safety assessment of omeprazole use: a review. Sao Paulo Med J. 2018;136(6):557-570. doi:10.1590/1516-3180.2018.0019220318.

Hatakeyama Y, Horino T, Matsumoto T, et al. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury. Clin Exp Nephrol. 2021;25(10):1087-1092. doi:10.1007/s10157-021-02066-z

Wang Y, Ye Z, Ge L, et al. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis. BMJ. 2020;368:l6744. doi:10.1136/bmj.l6744

Tariq R, Singh S, Gupta A, et al. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis. JAMA Intern Med. 2017;177(6):784-791. doi:10.1001/jamainternmed.2017.0212

Mendes JJ, Silva MJ, Miguel LS, et al. Sociedade Portuguesa de Cuidados Intensivos guidelines for stress ulcer prophylaxis in the intensive care unit. Diretrizes da Sociedade Portuguesa de Cuidados Intensivos para profilaxia da úlcera de estresse na unidade de terapia intensiva. Rev Bras Ter Intensiva. 2019;31(1):5-14. doi:10.5935/0103-507X.20190002

Biyase N, Perrie H, Scribante J, Muteba M, Chetty S. Stress ulcer prophylaxis use in critical care units at public hospitals in Johannesburg, South Africa. South Afr J Crit Care.2021;37(1):10.7196/SAJCC.2021.v37i1.439. doi:10.7196/SAJCC.2021.v37i1.439

Araújo SN, Santos YS, Santos JA, et al. Estimativa de custo e adesão de prescrições médicas a diretrizes de profilaxia para úlcera de estresse em um hospital universitário no Nordeste do Brasil: estudo retrospectivo observacional. Rev Bras Farm Hosp Serv Saude. 2021;12(3):0648. doi: 10.30968/rbfhss.2021.123.0648.

Choi YH, Lee JH, Shin JJ, Cho YS. A revised risk analysis of stress ulcers in burn patients receiving ulcer prophylaxis. Clin Exp Emerg Med. 2015;2(4):250-255. doi:10.15441/ceem.15.076

Franchitti M, Piubellini J, Sadeghipour F, et al. Adequacy of stress ulcer prophylaxis prescription in the intensive care unit: an observational study. Swiss Med Wkly. 2020;150:w20322. doi:10.4414/smw.2020.20322

Farsaei S, Ghorbani S, Adibi P. Variables Associated with Adherence to Stress Ulcer Prophylaxis in Patients Admitted to the General Hospital Wards: A Prospective Study. Adv Pharm Bull. 2017;7(1):73-80. doi:10.15171/apb.2017.009

Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5(6):368-375. doi:10.1186/cc1071

Horsa BA, Ayele Y, Ayalew MB. Assessment of pharmacologic prophylaxis use against stress ulcer in the medical wards of University of Gondar Hospital. SAGE Open Med. 2019;7:2050312119827409. doi:10.1177/2050312119827409

Bez C, Perrottet N, Zingg T, et al. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department. J Eval Clin Pract. 2013;19(2):374-378. doi:10.1111/j.1365-2753.2012.01838.x

Oliveira RCC, Malafaia O, Tabushi FI, et al. Prescrições em unidade de terapia intensiva devem adequar-se aos fatores de risco na prevenção de sangramento por úlcera de estresse. Arq Bras Cir Dig. 2021;34(3):e1587. doi:10.1590/0102-672020210003e1587.

Palm NM, McKinzie B, Ferguson PL, et al. Pharmacologic Stress Gastropathy Prophylaxis May Not Be Necessary in At-Risk Surgical Trauma ICU Patients Tolerating Enteral Nutrition. J Intensive Care Med. 2018;33(7):424-429. doi:10.1177/0885066616678385

Hamilton LA, Darby SH, Rowe AS. A Retrospective Cohort Analysis of the Use of Enteral Nutrition Plus PharmacologicProphylaxis or Enteral Nutrition Alone. Hosp Pharm. 2021;56(6):729-736. doi:10.1177/0018578720954159.

Mosier MJ, Pham TN, Klein MB, et al. Early enteral nutrition in burns: compliance with guidelines and associated outcomes in a multicenter study. J Burn Care Res. 2011;32(1):104-109. doi:10.1097/BCR.0b013e318204b3be.

El-Kersh K, Jalil B, McClave SA, et al. Enteral nutrition as stress ulcer prophylaxis in critically ill patients: A randomized controlled exploratory study. J Crit Care. 2018;43:108-113. doi:10.1016/j.jcrc.2017.08.036

Raff T, Germann G, Hartmann B. The value of early enteral nutrition in the prophylaxis of stress ulceration in the severely burned patient. Burns. 1997;23(4):313-318. doi:10.1016/s0305-4179(97)89875-0

Huang HB, Jiang W, Wang CY, et al. Stress ulcer prophylaxis in intensive care unit patients receiving enteral nutrition: a systematic review and meta-analysis. Crit Care. 2018;22(1):20. doi:10.1186/s13054-017-1937-1

McGraw C, Briscoe A, Reynolds C, et al. Outcomes of patients with traumatic brain injury after stress ulcer prophylaxis: a retrospective multicenter study. Trauma Surg Acute Care Open. 2024;9(1):e001285. doi:10.1136/tsaco-2023-001285

Anwar F, Al-Khayer A, El-Mahrouki H, et al. Gastrointestinal bleeding in spinal injuries patient: Is prophylaxis essential? British Journal of Medical Practitioners. 2013;6(1):a607.

Park WG, Rouse RV, Kahng IS, et al. Giant gastric ulcers in chronic spinal cord injury patients. Case report. Digestive Endoscopy. 2007;19,36–39. doi:10.1111/j.1443-1661.2007.00666.x

Barletta JF, Sclar DA. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Crit Care. 2014;18(6):714. doi:10.1186/s13054-014-0714-7

Ogasawara O, Kojima T, Miyazu M, Sobue K. Impact of the stress ulcer prophylactic protocol on reducing the unnecessary administration of stress ulcer medications and gastrointestinal bleeding: a single-center, retrospective pre-post study. J Intensive Care. 2020;8:10. doi:10.1186/s40560-020-0427-8

Orelio CC, Heus P, Kroese-van Dieren JJ, Spijker R, van Munster BC, Hooft L. Reducing Inappropriate Proton Pump Inhibitors Use for Stress Ulcer Prophylaxis in Hospitalized Patients: Systematic Review of De-Implementation Studies. J Gen Intern Med. 2021;36(7):2065-2073. doi:10.1007/s11606-020-06425-6.

Downloads

Published

2025-06-25

How to Cite

1.
SILVA FD, CARVALHO FB, MAGALHÃES AC. Evaluation of Omeprazole prescription for stress ulcer prophylaxis in a public trauma referral hospital: monocentric cross-sectional study. J Hosp Pharm Health Serv [Internet]. 2025Jun.25 [cited 2025Jun.30];16(2):e1206. Available from: https://jhphs.org/sbrafh/article/view/1206

Issue

Section

ORIGINAL ARTICLES